These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 27316778)

  • 1. Rectal 1% Tenofovir Gel Use Associates with Altered Epidermal Protein Expression.
    Romas L; Birse K; Mayer KH; Abou M; Westmacott G; Giguere R; Febo I; Cranston RD; Carballo-Diéguez A; McGowan I; Burgener A
    AIDS Res Hum Retroviruses; 2016; 32(10-11):1005-1015. PubMed ID: 27316778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Phase 1 Randomized, Open Label, Rectal Safety, Acceptability, Pharmacokinetic, and Pharmacodynamic Study of Three Formulations of Tenofovir 1% Gel (the CHARM-01 Study).
    Mcgowan I; Cranston RD; Duffill K; Siegel A; Engstrom JC; Nikiforov A; Jacobson C; Rehman KK; Elliott J; Khanukhova E; Abebe K; Mauck C; Spiegel HM; Dezzutti CS; Rohan LC; Marzinke MA; Hiruy H; Hendrix CW; Richardson-Harman N; Anton PA
    PLoS One; 2015; 10(5):e0125363. PubMed ID: 25942472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the griffithsin anti-HIV microbicide and placebo gels on the rectal mucosal proteome and microbiome in non-human primates.
    Girard L; Birse K; Holm JB; Gajer P; Humphrys MS; Garber D; Guenthner P; Noël-Romas L; Abou M; McCorrister S; Westmacott G; Wang L; Rohan LC; Matoba N; McNicholl J; Palmer KE; Ravel J; Burgener AD
    Sci Rep; 2018 May; 8(1):8059. PubMed ID: 29795295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicompartmental Pharmacokinetic Model of Tenofovir Delivery to the Rectal Mucosa by an Enema.
    Gao Y; Katz DF
    PLoS One; 2017; 12(1):e0167696. PubMed ID: 28114388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Label-free analysis of tenofovir delivery to vaginal tissue using co-registered confocal Raman spectroscopy and optical coherence tomography.
    Chuchuen O; Maher JR; Henderson MH; Desoto M; Rohan LC; Wax A; Katz DF
    PLoS One; 2017; 12(9):e0185633. PubMed ID: 28961280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Clinical Pharmacokinetics and Pharmacodynamics of HIV-1 Integrase Strand Transfer Inhibitors.
    Podany AT; Scarsi KK; Fletcher CV
    Clin Pharmacokinet; 2017 Jan; 56(1):25-40. PubMed ID: 27317415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adherence to Pre-Exposure Prophylaxis for HIV Prevention in a Clinical Setting.
    Montgomery MC; Oldenburg CE; Nunn AS; Mena L; Anderson P; Liegler T; Mayer KH; Patel R; Almonte A; Chan PA
    PLoS One; 2016; 11(6):e0157742. PubMed ID: 27333000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurocognition with maraviroc compared with tenofovir in HIV.
    Robertson KR; Miyahara S; Lee A; Brown TT; Chan ES; Berzins B; Rusin D; Eron JJ; Taiwo BO;
    AIDS; 2016 Sep; 30(15):2315-21. PubMed ID: 27333088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 Drug Resistance by Ultra-Deep Sequencing Following Short Course Zidovudine, Single-Dose Nevirapine, and Single-Dose Tenofovir with Emtricitabine for Prevention of Mother-to-Child Transmission.
    Samuel R; Julian MN; Paredes R; Parboosing R; Moodley P; Singh L; Naidoo A; Gordon M
    J Acquir Immune Defic Syndr; 2016 Dec; 73(4):384-389. PubMed ID: 27327263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protocol for an open-label, single-arm trial of HIV pre-exposure prophylaxis (PrEP) among people at high risk of HIV infection: the NSW Demonstration Project PRELUDE.
    Vaccher S; Grulich A; McAllister J; Templeton DJ; Bloch M; McNulty A; Holden J; Poynten IM; Prestage G; Zablotska I;
    BMJ Open; 2016 Jun; 6(6):e012179. PubMed ID: 27324719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmaceutical Equivalence of Distributed Generic Antiretroviral (ARV) in Asian Settings: The Cross-Sectional Surveillance Study - PEDA Study.
    Sapsirisavat V; Vongsutilers V; Thammajaruk N; Pussadee K; Riyaten P; Kerr S; Avihingsanon A; Phanuphak P; Ruxrungtham K;
    PLoS One; 2016; 11(6):e0157039. PubMed ID: 27322409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using Population Pharmacokinetic and Pharmacodynamic Analyses of Entecavir in Pediatric Subjects to Simplify Dosing Recommendations.
    Chan P; Mould DR; Tarif MA; Reynolds L; LaCreta F; Bertz R; Bifano M
    Clin Pharmacokinet; 2016 Dec; 55(12):1559-1572. PubMed ID: 27319000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The trend of transmitted drug resistance in newly diagnosed antiretroviral-naive HIV/AIDS patients during 1999-2012 in South Korea.
    Park M; Kee MK; Rhee J; Park JY; Kim SS; Kang C; Choi JY
    J Clin Virol; 2016 Aug; 81():53-7. PubMed ID: 27317880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Women for science and science for women: Gaps, challenges and opportunities towards optimizing pre-exposure prophylaxis for HIV-1 prevention.
    Karim QA; Archary D; Barré-Sinoussi F; Broliden K; Cabrera C; Chiodi F; Fidler SJ; Gengiah TN; Herrera C; Kharsany ABM; Liebenberg LJP; Mahomed S; Menu E; Moog C; Scarlatti G; Seddiki N; Sivro A; Cavarelli M
    Front Immunol; 2022; 13():1055042. PubMed ID: 36561760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term oral pre-exposure prophylaxis against HIV-1 modulates the transcriptome of foreskin tissue in young men in Africa.
    Petkov S; Herrera C; Else L; Lebina L; Opoka D; Seiphetlo TB; Pillay AA; Mugaba S; Namubiru P; Odoch G; Ssemata AS; Serwanga J; Kaleebu P; Webb EL; Khoo S; Martinson N; Gray CM; Fox J; Chiodi F
    Front Immunol; 2022; 13():1009978. PubMed ID: 36479111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mobilization of systemic CCL4 following HIV pre-exposure prophylaxis in young men in Africa.
    Petkov S; Herrera C; Else L; Mugaba S; Namubiru P; Odoch G; Opoka D; Pillay AAP; Seiphetlo TB; Serwanga J; Ssemata AS; Kaleebu P; Webb EL; Khoo S; Lebina L; Gray CM; Martinson N; Fox J; Chiodi F
    Front Immunol; 2022; 13():965214. PubMed ID: 35967369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV Pathogenesis in the Human Female Reproductive Tract.
    Rodriguez-Garcia M; Connors K; Ghosh M
    Curr HIV/AIDS Rep; 2021 Apr; 18(2):139-156. PubMed ID: 33721260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simian Immunodeficiency Virus Susceptibility, Immunology, and Microbiome in the Female Genital Tract of Adolescent Versus Adult Pigtail Macaques.
    Berard AR; Miller C; Araínga M; Broedlow CA; Noël-Romas L; Schifanella L; Hensley-McBain T; Roederer A; Driscoll CB; Coronado E; Manuzak J; McKinnon LR; Villinger F; Hope TJ; Burgener AD; Klatt NR
    AIDS Res Hum Retroviruses; 2021 Jul; 37(7):510-522. PubMed ID: 33446027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Q-Griffithsin anti-HIV microbicide gel in non-human primates: In situ analyses of epithelial and immune cell markers in rectal mucosa.
    Günaydın G; Edfeldt G; Garber DA; Asghar M; Noȅl-Romas L; Burgener A; Wählby C; Wang L; Rohan LC; Guenthner P; Mitchell J; Matoba N; McNicholl JM; Palmer KE; Tjernlund A; Broliden K
    Sci Rep; 2019 Dec; 9(1):18120. PubMed ID: 31792342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized, placebo controlled phase I trial of safety, pharmacokinetics, pharmacodynamics and acceptability of tenofovir and tenofovir plus levonorgestrel vaginal rings in women.
    Thurman AR; Schwartz JL; Brache V; Clark MR; McCormick T; Chandra N; Marzinke MA; Stanczyk FZ; Dezzutti CS; Hillier SL; Herold BC; Fichorova R; Asin SN; Rollenhagen C; Weiner D; Kiser P; Doncel GF
    PLoS One; 2018; 13(6):e0199778. PubMed ID: 29953547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.